164 related articles for article (PubMed ID: 32439911)
1. Clinically relevant mutations in mycobacterial LepA cause rifampicin-specific phenotypic resistance.
Wang BW; Zhu JH; Javid B
Sci Rep; 2020 May; 10(1):8402. PubMed ID: 32439911
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive phenotypic characterization of rifampicin resistance mutations in Salmonella provides insight into the evolution of resistance in Mycobacterium tuberculosis.
Brandis G; Pietsch F; Alemayehu R; Hughes D
J Antimicrob Chemother; 2015 Mar; 70(3):680-5. PubMed ID: 25362573
[TBL] [Abstract][Full Text] [Related]
3. Unique Mode of Cell Division by the Mycobacterial Genetic Resister Clones Emerging
Jakkala K; Paul A; Pradhan A; Nair RR; Sharan D; Swaminath S; Ajitkumar P
mSphere; 2020 Nov; 5(6):. PubMed ID: 33208519
[TBL] [Abstract][Full Text] [Related]
4. Selective Pressure by Rifampicin Modulates Mutation Rates and Evolutionary Trajectories of Mycobacterial Genomes.
Cebrián-Sastre E; Chiner-Oms A; Torres-Pérez R; Comas I; Oliveros JC; Blázquez J; Castañeda-García A
Microbiol Spectr; 2023 Aug; 11(4):e0101723. PubMed ID: 37436169
[TBL] [Abstract][Full Text] [Related]
5. Rifampicin can induce antibiotic tolerance in mycobacteria via paradoxical changes in rpoB transcription.
Zhu JH; Wang BW; Pan M; Zeng YN; Rego H; Javid B
Nat Commun; 2018 Oct; 9(1):4218. PubMed ID: 30310059
[TBL] [Abstract][Full Text] [Related]
6. Novel insertion and deletion mutants of RpoB that render Mycobacterium smegmatis RNA polymerase resistant to rifampicin-mediated inhibition of transcription.
Malshetty V; Kurthkoti K; China A; Mallick B; Yamunadevi S; Sang PB; Srinivasan N; Nagaraja V; Varshney U
Microbiology (Reading); 2010 May; 156(Pt 5):1565-1573. PubMed ID: 20150242
[TBL] [Abstract][Full Text] [Related]
7. Rifampicin resistance mutations in the 81 bp RRDR of rpoB gene in Mycobacterium tuberculosis clinical isolates using Xpert MTB/RIF in Khyber Pakhtunkhwa, Pakistan: a retrospective study.
Ullah I; Shah AA; Basit A; Ali M; Khan A; Ullah U; Ihtesham M; Mehreen S; Mughal A; Javaid A
BMC Infect Dis; 2016 Aug; 16():413. PubMed ID: 27519406
[TBL] [Abstract][Full Text] [Related]
8. Role of an RNA polymerase interacting protein, MsRbpA, from Mycobacterium smegmatis in phenotypic tolerance to rifampicin.
Dey A; Verma AK; Chatterji D
Microbiology (Reading); 2010 Mar; 156(Pt 3):873-883. PubMed ID: 19926651
[TBL] [Abstract][Full Text] [Related]
9. Growth and division mechanisms by which genetic resisters emerge from the rifampicin-surviving population of differentially antibiotic-susceptible mycobacterial subpopulations.
Jakkala K; Paul A; Nair RR; Swaminath S; Pradhan A; Ajitkumar P
Int J Mycobacteriol; 2022; 11(3):273-286. PubMed ID: 36260446
[TBL] [Abstract][Full Text] [Related]
10. Occurrence of disputed rpoB mutations among Mycobacterium tuberculosis isolates phenotypically susceptible to rifampicin in a country with a low incidence of multidrug-resistant tuberculosis.
Al-Mutairi NM; Ahmad S; Mokaddas E; Eldeen HS; Joseph S
BMC Infect Dis; 2019 Jan; 19(1):3. PubMed ID: 30606116
[TBL] [Abstract][Full Text] [Related]
11. High-throughput mutagenesis and screening approach for the identification of drug-resistant mutations in the rifampicin resistance-determining region of mycobacteria.
Zhao H; Li J; Feng S; Xu L; Yan B; Li C; Li M; Wang Y; Li Y; Liang L; Zhou D; Wan J; Wang W; Tian GB; Gu B; Huang X
Int J Antimicrob Agents; 2024 Jun; 63(6):107158. PubMed ID: 38537722
[TBL] [Abstract][Full Text] [Related]
12. The K+ uptake regulator TrkA controls membrane potential, pH homeostasis and multidrug susceptibility in Mycobacterium smegmatis.
Castañeda-García A; Do TT; Blázquez J
J Antimicrob Chemother; 2011 Jul; 66(7):1489-98. PubMed ID: 21613307
[TBL] [Abstract][Full Text] [Related]
13. A rifampin-hypersensitive mutant reveals differences between strains of Mycobacterium smegmatis and presence of a novel transposon, IS1623.
Alexander DC; Jones JR; Liu J
Antimicrob Agents Chemother; 2003 Oct; 47(10):3208-13. PubMed ID: 14506032
[TBL] [Abstract][Full Text] [Related]
14. Association of rpoB mutations with rifampicin resistance in Mycobacterium avium.
Obata S; Zwolska Z; Toyota E; Kudo K; Nakamura A; Sawai T; Kuratsuji T; Kirikae T
Int J Antimicrob Agents; 2006 Jan; 27(1):32-9. PubMed ID: 16368226
[TBL] [Abstract][Full Text] [Related]
15. Absence of hybridization with the wild-type and mutant rpoB probes in the Genotype MTBDRplus assay detects 'disputed' rifampicin mutations.
Abanda NN; Djieugoué JY; Khadka VS; Pefura-Yone EW; Mbacham WF; Vernet G; Penlap VM; Deng Y; Eyangoh SI; Taylor DW; Leke RGF
Clin Microbiol Infect; 2018 Jul; 24(7):781.e1-781.e3. PubMed ID: 29217277
[TBL] [Abstract][Full Text] [Related]
16. Temporal and intrinsic factors of rifampicin tolerance in mycobacteria.
Richardson K; Bennion OT; Tan S; Hoang AN; Cokol M; Aldridge BB
Proc Natl Acad Sci U S A; 2016 Jul; 113(29):8302-7. PubMed ID: 27357669
[TBL] [Abstract][Full Text] [Related]
17. Mutations outside the rifampicin resistance-determining region associated with rifampicin resistance in Mycobacterium tuberculosis.
Siu GK; Zhang Y; Lau TC; Lau RW; Ho PL; Yew WW; Tsui SK; Cheng VC; Yuen KY; Yam WC
J Antimicrob Chemother; 2011 Apr; 66(4):730-3. PubMed ID: 21393153
[TBL] [Abstract][Full Text] [Related]
18. The occurrence of rare rpoB mutations in rifampicin-resistant clinical Mycobacterium tuberculosis isolates from Kuwait.
Ahmad S; Mokaddas E
Int J Antimicrob Agents; 2005 Sep; 26(3):205-12. PubMed ID: 16099622
[TBL] [Abstract][Full Text] [Related]
19. Mutation of tlyA confers capreomycin resistance in Mycobacterium tuberculosis.
Maus CE; Plikaytis BB; Shinnick TM
Antimicrob Agents Chemother; 2005 Feb; 49(2):571-7. PubMed ID: 15673735
[TBL] [Abstract][Full Text] [Related]
20. Characterization of rifampicin-resistant clinical Helicobacter pylori isolates from Germany.
Glocker E; Bogdan C; Kist M
J Antimicrob Chemother; 2007 May; 59(5):874-9. PubMed ID: 17350989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
